Cancer Diagnostic firm Exact Sciences in advanced negotiations to acquire Genomic Health Inc for $2.8 billion
A potential could be announced as early as next week. According to a report from Bloomberg, Exact Sciences Corp, a cancer diagnostics company, is in advanced negotiations to acquire Genomic Health Inc for around $2.8 billion in order to strengthen its cancer testing unit. The potential deal could be announced as early as next week;…
